GlaxoSmithkline Healthcare net up 4.3 pc in Q2

Top Stories

»	Govt launches 20 critical mineral blocks, unveils ANVESH and EKAM portals
»	Sensex touches 80,000 mark on strong FII comeback in festive season
»	Rupee opens 29 paise higher, Brent crude falls 1 pc on hopes of Iran war exit
»	Sensex, Nifty open up to 2 pc higher after US election outcome, falling crude oil
»	India’s manufacturing sector clocks robust growth

SME Times News Bureau | 08 Nov, 2017
GlaxoSmithkline Consumer Healthcare Ltd on Tuesday reported a Rs 192-crore net profit for the second quarter (Q2) of fiscal 2017-18, registering a marginal 4.3 per cent annual growth from Rs 184 crore in the same period last year.

Sequentially, however, the net profit for Q2 is 46 per cent up from Rs 132 crore posted in the last quarter.

In a regulatory filing on the BSE, the NCR-based company said the revenue from operations at Rs 1,115 crore for Q2 was 6.5 per cent annually lower than Rs 1,193 crore in the like period of last year but up 6.6 per cent sequentially from Rs 1,046 crore in the last quarter.

The blue chip company's scrip of Rs 10 face value lost Rs 43 per share in Tuesday's trading on the BSE to end at Rs 5,466.05 from Monday's closing rate of Rs 5,509.65 and opening price of Rs 5,549.95.